leisure time -WSS

leisure time

author：focus 2025-10-01 00:48:06 - browse：18

NIH headquarters — NIH research fellows want to unionize, in large part because they want a raise. Will that mean less money for grants? Lydia Polimeni/NIH

Several thousand research fellows at the National Institutes of Health want to unionize, in large part because they want to raise their pay stipends to something resembling a living wage near the agency headquarters in Bethesda, Md. But with a Congress that is looking on in suspicion at the NIH’s research and a debt ceiling deal that limits budget increases, where is the money going to come from?

Unlike private companies, federal agencies can’t always just give raises. This varies widely across the government, and from position to position. NIH trainees actually have it better than most, because they aren’t subject to the rigid federal pay scale that governs how much most people working in the administration can make. That doesn’t mean, however, that there’s always money for raises. It’s Congress, not the NIH itself, that sets the agency’s budget.

Finding money for raises, therefore, necessarily means taking money from somewhere else, said Richard Freeman, a professor of economics at Harvard.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： When a patient nears the end, a feared therapy can comfort

focus

WSS

A new ‘biological computer' targets cancer while sparing healthy cells

The real point of Kenneth Smith’s execution by nitrogen gas

Time to name cancers by genetics, not organ of origin, expert says

Are infertility treatments 'essential' during the Covid

Cybersecurity threat forces Lurie Children's to take systems offline

Congressmen charge Covid hearing ‘could have been an email’

focus

leisure time

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Caribou posts encouraging results on off

Activists slam private health insurers over coverage restrictions

Scientists grapple with ethics of stem cell research

Alkermes shareholders re

Biden administration opens offers in Medicare drug price negotiations

BioMarin wins approval for gene therapy to treat hemophilia A

In rare move, senator releases unverified FBI source report alleging Biden bribe

23andMe had bad news about my health. I wish a person had delivered it

The stock market has soared this year, but will it last? Experts weigh in

leisure time

What we need to know about Arena Bioworks

Extensive review finds private equity owners jack up cost of care

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Vertex non

Apple Vision Pro: A first look at health apps on the new VR headset

The lessons of Aduhelm, an Alzheimer's drug that was not to be

focus

focus

entertainment

explore